Early recognition of catastrophic antiphospholipid syndrome in patients with antiphospholipid syndrome based on a Chinese cohort

被引:0
作者
Huang, C. [1 ]
Zhao, Y. [1 ]
Tian, X. [1 ]
Wang, Q. [1 ]
Hu, C. [1 ]
Jiang, N. [1 ]
Zhou, S. [1 ]
Zhang, L. [1 ]
Zhou, J. [1 ]
Wu, C. [1 ]
Li, J. [1 ]
Wu, D. [1 ]
Zhao, J. [1 ,2 ]
Li, M. [1 ]
Zeng, X. [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp PUMCH, Dept Rheumatol & Clin Immunol,Minist Sci & Technol, Natl Clin Res Ctr Dermatol & Immunol Dis NCRC DID,, Beijing, Peoples R China
[2] 1 Dongshuaifuyuan, Beijing 100730, Peoples R China
关键词
antiphospholipid syndrome; catastrophic antiphospholipid syndrome; diagnosis; INTERNATIONAL CONSENSUS STATEMENT; CLASSIFICATION CRITERIA; PATHOGENESIS; MULTICENTER; THROMBOSIS; ARTERIAL; FEATURES; DISEASE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveCatastrophic antiphospholipid syndrome (CAPS) is a life-threatening form of antiphospholipid syndrome (APS) with high mortality. We try to develop a predictive model to achieve early recognition of CAPS. MethodsData of APS patients referred into Peking Union Medical College Hospital from May 2013 to October 2021 was collected. A binary logistic regression method was used to identify predictors of CAPS, coefficient B was assigned with score value in the development of prediction model, and risk-stratification was based on the calculated scores using the model.ResultsTwenty-seven CAPS (11.9%) occurred in 226 APS patients. CAPS was more likely to occur in male secondary APS patients with a history of hypertension, hyperlipidaemia, and arterial thrombosis, presented with haematological, nephrological and immunological abnormalities simultaneously. Hypertension history (OR 5.091, 95% CI 1.119-23.147), anaemia (OR 116.231, 95% CI 10.512-1285.142), elevated LDH (OR 59.743, 95% CI 7.439-479.815) and proteinuria (OR 11.265, 95% CI 2.118-59.930) were independent predictors for CAPS, and the scores were 1, 3, 3 and 2 points, respectively. The risk scores were divided into high-risk (6-9) and low risk (0-5), the risk for CAPS were 54.1% and 0.6%, with sensitivity of 0.963 and specificity of 0.886. The Nagelkerke's R2 (0.739) and the Omnibus test (?(2) =109.231, df=4, p=0.000) indicated the model has a good fit. The AUC of 0.971 indicated good discrimination. The calibration curve in internal validation showed good calibration of this predictive model.ConclusionA predictive model of CAPS was developed with hypertension, anaemia, elevated LDH and proteinuria. This model could help identify CAPS in high-risk patients, achieve early recognition and intervention to improve prognosis.
引用
收藏
页码:1017 / 1023
页数:7
相关论文
共 50 条
[31]   Reversible cardiac valvular disease in catastrophic antiphospholipid syndrome [J].
Teunisse, C. C. ;
Kalsbeek, A. J. ;
de Vries, S. T. ;
Huisman, S. J. ;
Boers, J. E. ;
Breeman, A. ;
Beukhof, J. R. .
NETHERLANDS JOURNAL OF MEDICINE, 2010, 68 (05) :215-220
[32]   Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome [J].
Bontadi, Agnese ;
Ruffatti, Amelia ;
Falcinelli, Emanuela ;
Giannini, Silvia ;
Marturano, Alessandro ;
Tonello, Marta ;
Hoxha, Ariela ;
Pengo, Vittorio ;
Punzi, Leonardo ;
Momi, Stefania ;
Gresele, Paolo .
THROMBOSIS AND HAEMOSTASIS, 2013, 109 (05) :901-908
[33]   Catastrophic Antiphospholipid Syndrome Diagnosis and Management in Pregnancy [J].
Gomez-Puerta, Jose A. ;
Espinosa, Gerard ;
Cervera, Ricard .
CLINICS IN LABORATORY MEDICINE, 2013, 33 (02) :391-+
[34]   Management of Anticoagulation and Antifibrinolytics in Catastrophic Antiphospholipid Syndrome [J].
Park, Jee Ha ;
Siddiqui, Nazia ;
Hrebec, William K. ;
Szymanski, Trevor J. ;
Uribe-Marquez, Santiago ;
Miletic, Kyle G. ;
Krishnan, Sandeep .
SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2024, 28 (03) :135-146
[35]   Catastrophic Antiphospholipid Syndrome: Onset and Outcome [J].
Reshetnyak, Tatiana M. ;
Alexandrova, Elena N. ;
Shtivalband, Inna B. ;
Lapovok, Stephka G. Rodenska, III ;
Seredavkina, Natalia V. ;
Satibaldieva, Maria A. ;
Nasonov, Evgenyi L. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) :S43-S44
[36]   Catastrophic antiphospholipid syndrome during pregnancy [J].
Fuentes Carrasco, Marta ;
Mayoral Triana, Alejandra ;
Cristobal Garcia, Ignacio Cristobal ;
Perez Perez, Noelia ;
Izquierdo Mendez, Nuria ;
Soler Ruiz, Patricia ;
Gonzalez Gonzalez, Virginia .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2021, 264 :21-24
[37]   The clinical significance of low complement levels in patients with catastrophic antiphospholipid syndrome: A descriptive analysis of 73 patients from the "Catastrophic antiphospholipid syndrome registry" [J].
Ponce, Ana ;
Rodriguez-Pinto, Ignasi ;
Basauli, Jose M. ;
Espinosa, Gerard ;
Erkan, Doruk ;
Shoenfeld, Yehuda ;
Cervera, Ricard .
LUPUS, 2022, 31 (10) :1218-1225
[38]   Liver involvement in catastrophic antiphospholipid syndrome [J].
Ozaras, R ;
Mert, A ;
Yilmaz, MH ;
Kumbasar, H ;
Tabak, F ;
Ozturk, R .
INTERNAL MEDICINE, 2004, 43 (04) :346-347
[39]   Catastrophic antiphospholipid syndrome and pancreatic cancer [J].
Ruano, M. ;
Oltra, R. ;
Martinez, F. ;
Oliver, V. ;
Forner, M. J. ;
Garcia-Fuster, M. J. .
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2007, 99 (01) :54-55
[40]   Catastrophic Antiphospholipid Syndrome: A Case Series [J].
Shiber, Shachaf ;
Molad, Yair .
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2013, 15 (09) :481-484